Skip to content

PTHS PTHS Operating margin

Operating margin at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
-17.2%-125pp
Journey Medical Corporation logo
Journey Medical CorporationDERM
-9.8%
Opko Health logo
Opko HealthOPK
-17.4%-5.6pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-103.9%-43.0pp
Theravance Biopharma logo
Theravance BiopharmaTBPH
1.2%+0.6pp
HRO
HarrowHROW
7.3%+5.2pp

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Calculated from PTHS’s reported figures.

Based on trailing twelve months.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's operating margin?
PTHS (PTHS) reported operating margin of -157.7% in Q1 2026.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.